🧪 New Insights: Mortality Risks from SARS-CoV-2 Variants
The EuCARE project has published a comprehensive study examining hospital mortality across Wild-type, Alpha, Delta, and Omicron waves of SARS-CoV-2. Here’s what you need to
The EuCARE project has published a comprehensive study examining hospital mortality across Wild-type, Alpha, Delta, and Omicron waves of SARS-CoV-2. Here’s what you need to
On November 21st, EuCARE proudly hosted the CCB Networking Session at the Demystifying Long COVID meeting. This high-level event provided the perfect platform to foster
We’re excited to invite all CCB members and conference attendees to join us for the CCB Networking Event hosted by EuCARE on November 21st at
📅 Save the Date!Join us on November 29th for the event “The Science of Pandemics: Past, Present, and Evidence-Based Strategies for the Future.” This is
How do SARS-COV-2 variants, coupled with other factors, influence the short- and long-term clinical course of COVID-19? Is the efficacy of vaccines or diagnostic tests affected as new variants emerge? Does treatment efficacy vary among variants? Do variants influence, and how, the spread in the school setting? Can we define a better testing and containment strategy in the school setting? What is the impact of containment measures, including schools closure, on pupils and teachers?
34 institutions from 4 continents collaborate to find answers to these and other crucial questions and to create a sustainable network to promptly tackle similar issues in the future.
FUNDED BY THE EC UNDER HORIZON-HLTH-2021-CORONA-01
- GRANT AGREEMENT NO 101046016
Get to know the project and its scope
Find out all the media news about the EuCARE Project.